Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.6706
-0.0150 (-2.19%)
At close: Aug 1, 2025, 4:00 PM
0.7030
+0.0324 (4.83%)
After-hours: Aug 1, 2025, 7:43 PM EDT
Accolade Market Cap
Adicet Bio has a market cap or net worth of $55.47 million as of August 1, 2025. Its market cap has decreased by -48.48% in one year.
Market Cap
55.47M
Enterprise Value
-78.73M
1-Year Change
-48.48%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $55.47M, a decrease of -81.61%. That is a compound annual growth rate of -29.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 55.47M | -30.03% |
| Dec 31, 2024 | 79.27M | -2.83% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
| Sep 16, 2020 | 301.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |